Creating tools to help patients make decisions about eosinophilic esophagitis treatment
Developing Patient-Centered Decision Support for Eosinophilic Esophagitis
This study is all about helping people with eosinophilic esophagitis (EoE) make better choices about their treatment by creating tools that guide them and their doctors in deciding between medications and diet changes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11060883 on NIH RePORTER |
What this research studies
This research focuses on developing patient-centered decision support tools to assist individuals with eosinophilic esophagitis (EoE) in making informed treatment choices. It aims to understand the factors that influence decision-making for patients and healthcare providers, particularly in the context of medication versus dietary therapies. By employing mixed methods and advanced qualitative research, the project seeks to enhance communication and education around treatment options, ultimately improving patient outcomes and quality of life.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with eosinophilic esophagitis who are navigating treatment options.
Not a fit: Patients without a diagnosis of eosinophilic esophagitis or those who are not actively involved in treatment decision-making may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could empower patients with eosinophilic esophagitis to make better-informed decisions regarding their treatment, leading to improved health outcomes.
How similar studies have performed: Previous research has shown promise in using patient-centered decision support tools in chronic disease management, indicating potential success for this approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Chang, Joy Weiling — University of Michigan at Ann Arbor
- Study coordinator: Chang, Joy Weiling
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.